116 related articles for article (PubMed ID: 7471319)
1. Amphotericin B plus combination chemotherapy for extensive non-small cell bronchogenic carcinoma.
Sarna G; Lowitz BB; Ganz PA; Cline MJ
Cancer Chemother Pharmacol; 1980; 5(2):89-92. PubMed ID: 7471319
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
Presant CA; Hillinger S; Klahr C
Cancer; 1980 Jan; 45(1):6-10. PubMed ID: 6243243
[TBL] [Abstract][Full Text] [Related]
3. Effects of amphotericin B with combination chemotherapy on response rates and on survival in non-small cell carcinoma of the lung.
Presant CA; Metter GE; Multhauf P; Bertrand M; Chang FF; Klein L; Rappaport D; Kendregan B; Mackie A
Cancer Treat Rep; 1984 Apr; 68(4):651-4. PubMed ID: 6201270
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
[No Abstract] [Full Text] [Related]
6. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
Dundalek E
Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
[No Abstract] [Full Text] [Related]
7. [Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].
Gropp C; Havemann K; Gassel WD; Hess F; Prignitz R; Schmidt M; Sodomann CP
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Dec; 90(3):301-6. PubMed ID: 146331
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of the non-small cell bronchogenic carcinoma].
Dimitriadis K; Boutis L; Tavantzis J; Mouratidou D; Bouchoris N; Koukourikos S; Hatzigogos K; Safarini S
Onkologie; 1983 Feb; 6(1):8-10. PubMed ID: 6189039
[TBL] [Abstract][Full Text] [Related]
9. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
Bitran JD; Desser RK; DeMeester T; Golomb HM
JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
[TBL] [Abstract][Full Text] [Related]
10. Small cell undifferentiated bronchogenic carcinoma: current status with emphasis upon the role of chemotherapy.
Johnson PS; Foley JF; Kessinger A; Lemon HM
J Surg Oncol; 1978; 10(6):549-57. PubMed ID: 215847
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma.
McMahon LJ; Jones SE; Durie BG; Salmon SE
Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213
[TBL] [Abstract][Full Text] [Related]
12. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinoma.
Schmidt AM; Blum RH; Clayton M; Speyer JL; Bottino J; Muggia FM
Am J Clin Oncol; 1984 Dec; 7(6):725-7. PubMed ID: 6543291
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma.
Krutchik AN; Buzdar AU; Blumenschein GR; Sinkovics JG
Cancer Treat Rep; 1978 Oct; 62(10):1565-7. PubMed ID: 709557
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of extensive large cell and adenocarcinoma of the lung: a randomized trial in 210 patients.
Vincent RG; Mehta CR; Tucker RD; Mountain CF; Cohen M; Wilson HE; Vogel C
Cancer; 1980 Jul; 46(2):256-60. PubMed ID: 6992978
[TBL] [Abstract][Full Text] [Related]
16. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
Miller CF; Weltz MD; Heim WJ; Blom J
Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
[No Abstract] [Full Text] [Related]
17. Combination chemotherapy in inoperable lung cancer--a trial of 2 regimens.
Behera D; Malik SK
Indian J Chest Dis Allied Sci; 1989; 31(1):21-4. PubMed ID: 2509339
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.
Ruckdeschel JC; Mehta CR; Salazar OM; Cohen M; Vogl S; Koons LS; Lerner H
Cancer Treat Rep; 1981; 65(11-12):965-72. PubMed ID: 7028258
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
Vogl SE; Wollner D; Kaplan BH; Berenzweig M
Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
[No Abstract] [Full Text] [Related]
20. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
